Mark Ma

4 Patents

• US125909772026

  Anti-ceruloplasmin Antibodies and Uses Thereof

  Alexion Pharmaceuticals, Inc.

  0 cites
• US119658842024

  Method of Quantitating Unbound C5 in a Sample

  Alexion Pharmaceuticals, Inc.

  0 cites
• US119516292024

  Systems, Apparatuses, and Methods for Cost Evaluation and Motion Planning for Robotic Devices

  Brain Corporation

  0 cites
• US118286832023

  Method of Quantitating Unbound C5a in a Sample

  Alexion Pharmaceuticals, Inc.

  0 cites